Diabetic Medicine

Researching how to realize the potential of diabetes prevention
pp. 1055-1057(3)
Authors: Simmons, R. K.; Griffin, S. J.; Wareham, N. J.

Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?
pp. 1058-1059(2)
Author: Currie, C. J.

United for diabetes: the route to the UN Resolution
pp. 1060-1061(2)
Author: Hirst, Michael

The importance of TCF7L2
pp. 1062-1066(5)
Author: Weedon, M. N.

The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies
pp. 1067-1072(6)
Authors: De Silva, N. M. G.; Steele, A.; Shields, B.; Knight, B.; Parnell, K.; Weedon, M. N.; Hattersley, A. T.; Frayling, T. M.

Identifying the special needs of children with Type 1 diabetes in the school setting. An overview of parents' perceptions
pp. 1073-1079(7)
Authors: Amillategui, B.; Calle, J. R.; Alvarez, M. A.; Cardiel, M. A.; Barrio, R.

Diabetic ketoacidosis and cerebral oedema in Sweden—a 2-year paediatric population study
pp. 1080-1085(6)
Authors: Hanas, R.; Lindgren, F.; Lindblad, B.

Fear of visual loss in patients with diabetes: results of the Prevalence of Diabetic Eye Disease in Tayside, Scotland (P-DETS) study
pp. 1086-1092(7)
Authors: Luckie, R.; Leese, G.; McAlpine, R.; MacEwen, C. J.; Baines, P. S.; Morris, A. D.; Ellis, J. D.

Ethnic differences in diabetic retinopathy
pp. 1093-1098(6)
Authors: Simmons, D.; Clover, G.; Hope, C.

Mild peripheral neuropathy prevents both leg muscular ischaemia and activation of exercise-induced coagulation in Type 2 diabetic patients with peripheral artery disease
pp. 1099-1104(6)
Authors: Piarulli, F.; Sambataro, M.; Minicuci, N.; Scarano, L.; Laverda, B.; Baiocchi, M. R.; Baldo-Enzi, G.; Galasso, S.; Bax, G.; Fedele, D.

The influence of exercise on foot perfusion in diabetes
pp. 1105-1111(7)
Authors: Williams, D. T.; Harding, K. G.; Price, P. E.

A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets
pp. 1112-1120(9)
Authors: Steuten, L. M. G.; Vrijhoef, H. J. M.; Landewé-Cleuren, S.; Schaper, N.; Van Merode, G. G.; Spreeuwenberg, C.

Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark
pp. 1121-1128(8)
Authors: Mai, K. S.; Sandbæk, A.; Borch-Johnsen, K.; Lauritzen, T.

Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus
pp. 1129-1135(7)
Authors: Pettitt, D. J.; Ospina, P.; Howard, C.; Zisser, H.; Jovanovic, L.

High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study
pp. 1136-1142(7)
Authors: Murussi, M.; Campagnolo, N.; Beck, M. O.; Gross, J. L.; Silveiro, S. P.

Characteristics of adults with and without cystic fibrosis-related diabetes
pp. 1143-1148(6)
Authors: Adler, A. I.; Gunn, E.; Haworth, C. S.; Bilton, D.

Time and cost involved in the care of newly registered patients with diabetes mellitus and other lifestyle diseases at diabetes clinics in Japan (JDDM 4)
pp. 1149-1155(7)
Authors: Oishi, M.; Yokoyama, H.; Abe, N.; Iwasaki, K.; Okuguchi, F.; Kawai, K.; Sugimoto, H.; Takamura, H.; Takeda, H.; Doi, K.; Hirao, K.; Ikeda, S.

Post-challenge glucose predicts coronary atherosclerotic progression in non-diabetic, post-menopausal women
pp. 1156-1159(4)
Authors: Mellen, P. B.; Bittner, V.; Herrington, D. M.

Establishing pragmatic estimated GFR thresholds to guide metformin prescribing
pp. 1160-1163(4)
Authors: Shaw, J. S.; Wilmot, R. L.; Kilpatrick, E. S.

Early mortality from the time of diagnosis of Type 2 diabetes: a 5-year prospective cohort study with a local age- and sex-matched comparison cohort
pp. 1164-1167(4)
Authors: Guzder, R. N.; Gatling, W.; Mullee, M. A.; Byrne, C. D.

Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality
pp. 1168-1171(4)
Authors: Vardakas, K. Z.; Siempos, I. I.; Falagas, M. E.

How many cases of Type 2 diabetes mellitus are due to being overweight in middle age? Evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records
pp. 1172-1172(1)
Author: Campbell, L. V.

Authors' response
pp. 1172-1173(2)
Authors: Hart, C. L.; Lawlor, D. A.; Smith, G. D.

Weight gain may contribute to increased fracture risk in women treated with rosiglitazone
pp. 1173-1174(2)
Authors: Pasco, J. A.; Henry, M. J.; Nicholson, G. C.

Diabetic retinopathy without diabetes
pp. 1174-1174(1)
Authors: Wright, A. D.; Dodson, P. M.

Authors' response
pp. 1174-1175(2)
Author: Nathan, D. M.

Excess day-time sleepiness in patients with diabetes: relationship between HbA_1c, BMI and vascular complications
pp. 1175-1176(2)
Authors: Iqbal, N.; Thomson, G.; Idris, I.

Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome)
pp. 1176-1178(3)
Authors: Sumnik, Z.; Kolouskova, S.; Wales, J. K. H.; Komarek, V.; Cinek, O.

Diary dates
pp. 1179-1179(1)